Titan Medical closes in on 1st-in-human for Sport surgical robot

Titan Medical (CVE:TMD) said this week that initial versions of its Sport robot-assisted surgery platform are ready for engineering verification ahead of 1st-in-human trials early next year.

The initial Sport versions to include both work station and patient cart are “precursors” for the systems to be built for the trials next year, Toronto-based Titan said.

“This fully integrated initial EV system represents the efforts of many people at Titan, our surgeon advisory board and our development contractors. This is a major accomplishment for Titan as we move toward our 1st-in-human trials,” clinical & regulatory affairs executive vice president Dennis Fowler said in prepared remarks.

“I am very pleased and excited that we are able to finish off the year with such a positive accomplishment. I would encourage readers to visit our web site at http://ift.tt/1jp369H where we have posted pictures of this complete initial Sport surgical system,” added chairman & CEO John Hargrove.

It’s been a busy season for Titan, which last week licensed “know-how and certain technology” from Mayo Clinic for the Sport device. In November the company inked an instrument development deal with Cadence Device, raised $4 million and $8.6 million in separate rounds, and signed a private placement deal with a subsidiary of Chinese medical device distributor Ningbo Long Hengtai International Trade Co. that could wind up being worth more than $24 million.

The post Titan Medical closes in on 1st-in-human for Sport surgical robot appeared first on MassDevice.

from MassDevice http://ift.tt/1JvmoWz